BACKGROUND AND OBJECTIVES: Standard or investigative immunosuppressive
therapies for cutaneous chronic graft-versus-host disease (GVHD) may prove not only …

Morphea, or localized scleroderma, can at times constitute a severely disabling and
aggressive disease with no single therapy proven to be curative or the standard of care …

Extracorporeal photopheresis (ExP) has been shown to be an efficacious and well-tolerated
therapy in the treatment of cutaneous T-cell lymphoma (CTCL) and systemic sclerosis …

Background: Extracorporeal photochemotherapy (EP) is used for the treatment of cutaneous
T-cell lymphoma (CTCL), progressive systemic sclerosis (PSS), pemphigus vulgaris, and …

This viewpoint considers four cutaneous unmet clinical needs of patients with systemic
sclerosis (SSc), namely the rapidly progressive skin thickening (scleroderma) which occurs …

Graft-versus-host disease (GVHD) is a frequent complication occurring after allogeneic
hematopoietic stem cell transplantation. It can be classified as acute and chronic GVHD …

Induction of apoptosis and changes to cytokine secretion patterns have been implicated in
the mechanism of action of extracorporeal photopheresis (ECP). Lymphocyte apoptosis is …

We report two female subjects with therapy‐resistant cutaneous lupus erythematosus (LE),
one with subacute cutaneous and the other chronic discoid LE, both treated with …

Systemic sclerosis is an uncommon autoimmune connective tissue disease with multiorgan
system involvement and significant associated morbidity and mortality. Cutaneous signs and …

We describe a patient with therapy-resistant cutaneous T-cell lymphoma, Sézary syndrome
variant, in association with concurrent polyarthritis and vitiligo, who was successfully treated …